Cancer Treatment ReviewsWelcome to the online submission and editorial system for Cancer Treatment Reviews.Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews.Each issue provides topical reviews under the following regular sections:• comments on controversy• tumor reviews• anti-tumor treatments• new drugs• complications of treatment• general and supportive care• laboratory/clinic interface.
癌症治疗评论欢迎来到癌症治疗评论的在线投稿和编辑系统。癌症治疗评论是一本国际性杂志，通过发表最新的权威评论，帮助临床医生和研究人员了解癌症治疗研究的最新进展。每期在以下常规章节提供专题评论：·争议评论·肿瘤评论·抗肿瘤治疗·新药·治疗并发症·一般和支持性护理·实验室/临床界面。
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.11.002
Molecular targeted therapy of glioblastoma.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101896
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.01.004
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.03.004
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.11.001
Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.11.006
Hedgehog signaling inhibitors in solid and hematological cancers.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.04.005
Checkpoint inhibitors in pancreatic cancer.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.06.005
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.05.003
eHealth for improving quality of life in breast cancer patients: A systematic review.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.01.003
EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.08.002
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.12.006
Proton therapy for treatment of intracranial benign tumors in adults: A systematic review.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.11.004
Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101909
Management of metastatic bladder cancer.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.04.002
B cell and B cell-related pathways for novel cancer treatments.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.12.001
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.05.007
Comparison and applicability of molecular classifications for gastric cancer.
来源期刊：Cancer treatment reviewsDOI：10.1016/J.CTRV.2019.05.005
Oligometastatic prostate cancer: The game is afoot.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.01.005
Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.10.013
Personalizing therapy for older adults with acute myeloid leukemia: Role of geriatric assessment and genetic profiling.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.04.001
FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinoma.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.06.003
Therapeutic landscape of metaplastic breast cancer.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.08.004
A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.11.003
Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.12.005
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.03.001
Opportunities of circulating tumor DNA in lung cancer.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.07.002
Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.02.001
Androgen receptor plasticity and its implications for prostate cancer therapy.
来源期刊：Cancer treatment reviewsDOI：10.1016/J.CTRV.2019.05.001
Innovation in oncology clinical trial design.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.01.001
Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.10.014
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101934
Gastroesophageal cancer: Navigating the immune and genetic terrain to improve clinical outcomes.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101950
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101895
Liquid biopsy for rectal cancer: A systematic review.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101893
Multiple myeloma: Role of autologous transplantation.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101929
Systematic review and meta-analysis of patient reported outcomes for nurse-led models of survivorship care for adult cancer patients.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2018.12.007
Trametinib in the treatment of multiple malignancies harboring MEK1 mutations.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101907
Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.05.006
The role of PET/CT in the modern treatment of Hodgkin lymphoma.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.06.002
Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101931
Whole exome sequencing of cell-free DNA - A systematic review and Bayesian individual patient data meta-analysis.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101951
Breast cancer vaccines: Heeding the lessons of the past to guide a path forward.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101947
Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101948
Should we favour the use of 5\u202f×\u202f5 preoperative radiation in rectal cancer.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101908
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.01.006
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101935
Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101944
Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.101930
Small cell and large cell neuroendocrine carcinoma of the larynx: A comparative analysis.
来源期刊：Cancer treatment reviewsDOI：10.1016/j.ctrv.2019.08.002
